Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Brim, Hassan ^a   Zahaf, Marwah ^b   Laiyemo, Adeyinka O ^b   Nouraie, Mehdi ^c   Pérez Pérez, Guillermo I ^d   Smoot, Duane T ^b   Lee, Edward ^a   Razjouyan, Hadie ^e   Ashktorab, Hassan ^b  

^a HOWARD UNIVERSITY   (United States)

^b HOWARD UNIVERSITY CANCER CENTER   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e MONMOUTH MEDICAL CENTER   (United States)

Author keywords

African Americans; Colorectal neoplasm; Forty year and older; Gastric lesion; H. pylori infection; Risk factors

Indexed keywords

BACTERIUM ANTIBODY; CAGA ANTIBODY; CAGA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; COLON BIOPSY; COLORECTAL ADENOMA; COLORECTAL POLYP; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; NONHUMAN; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SEX RATIO; TUMOR LOCALIZATION; TUMOR VOLUME; BIOPSY; COLON POLYP; COLORECTAL TUMOR; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BIOPSY; COLONIC POLYPS; COLORECTAL NEOPLASMS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84900512250     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-296     Document Type: Article

References (58)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
2. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001, 93(17):1307-1313. 10.1093/jnci/93.17.1307, 11535705.
3. Jass JR. Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer. Am J Clin Pathol 2003, 119(6):773-775. 10.1309/UYN70N9W2DVN9ART, 12817423.
4. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009, 7(7):770-775. quiz 711, 10.1016/j.cgh.2008.12.030, 19268269.
5. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134(5):1570-1595. 10.1053/j.gastro.2008.02.002, 18384785.
6. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, . and the National Polyp Study Workgroup Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329(27):1977-1981. 10.1056/NEJM199312303292701, 8247072, and the National Polyp Study Workgroup.
7. Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev 2008, 17(11):2970-2979. 10.1158/1055-9965.EPI-08-0571, 2676114, 18990738.
8. Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL, Schauer DB, Dedon PC, Fox JG, Samson LD. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 2008, 118(7):2516-2525. 2423313, 18521188.
9. Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect 1995, 103(Suppl 8):263-268. 10.1289/ehp.95103s8263, 1518971, 8741796.
10. Dejea C, Wick E, Sears CL. Bacterial oncogenesis in the colon. Future Microbiol 2013, 8(4):445-460. 10.2217/fmb.13.17, 23534358.
11. Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, Tatsuguchi A, Gudis K, Yokoi K, Tanaka N, Yamashita K, Tajiri T, Ohaki Y, Sakamoto C. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005, 40(9):887-893. 10.1007/s00535-005-1649-1, 16211345.
12. Zhang Y, Gao C, Zhai JH. [Meta-analysis on the relationship between colorectal cancer and Helicobacter pylori infection]. Zhonghua Liu Xing Bing Xue Za Zhi 2009, 30(1):73-77.
13. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis 2008, 23(9):875-882. 10.1007/s00384-008-0479-z, 18506454.
14. Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, Rothenbacher D. Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. Eur J Cancer 2007, 43(8):1283-1289. 10.1016/j.ejca.2007.03.005, 17446060.
15. D'Onghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini F, Marzocca G, Bernini A, Campagna S, Marinello E, Vannoni D. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother 2007, 61(2-3):137-141.
16. Georgopoulos SD, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG, Ladas SD. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006, 74(1):42-46. 10.1159/000096593, 17068397.
17. Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC, Karczewska E, Bielanski W, Marlicz K, Starzynska T, Lawniczak M, Hahn EG. Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis 2001, 16(4):202-210. 10.1007/s003840100288, 11515678.
18. Siddheshwar RK, Gray JC, Kelly SB. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 2001, 48(1):47-52. 10.1136/gut.48.1.47, 1728168, 11115822.
19. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, Albanes D. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002, 11(10 Pt 1):1095-1099.
20. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995, 87(10):762-763. 10.1093/jnci/87.10.762, 7563155.
21. Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, Baron JA. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol 2009, 7(2):163-167. 10.1016/j.cgh.2008.09.006, 18929688.
22. Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001, 96(1):84-88. 10.1111/j.1572-0241.2001.03355.x, 11197293.
23. Bae RC, Jeon SW, Cho HJ, Jung MK, Kweon YO, Kim SK. Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World J Gastroenterol 2009, 15(45):5722-5726. 10.3748/wjg.15.5722, 2789227, 19960571.
24. Bulajic M, Stimec B, Ille T, Jesenofsky R, Kecmanovic D, Pavlov M, Ceranic M, Schneider-Brachert W, Lowenfels A, Maisonneuve P, Lohr J. PCR detection of helicobacter pylori genome in colonic mucosa: normal and malignant. Prilozi 2007, 28(2):25-38.
25. Bulajic M, Stimec B, Jesenofsky R, Kecmanovic D, Ceranic M, Kostic N, Schneider-Brachert W, Lowenfels A, Maisonneuve P, Lohr JM. Helicobacter pylori in colorectal carcinoma tissue. Cancer Epidemiol Biomarkers Prev 2007, 16(3):631-633. 10.1158/1055-9965.EPI-06-1031, 17372266.
26. Grahn N, Hmani-Aifa M, Fransen K, Soderkvist P, Monstein HJ. Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol 2005, 54(Pt 11):1031-1035.
27. Jones NL, Day AS, Jennings HA, Sherman PM. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 1999, 67(8):4237-4242. 96730, 10417197.
28. Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005, 117(6):1058-1059. 10.1002/ijc.21280, 15986436.
29. Soylu A, Ozkara S, Alis H, Dolay K, Kalayci M, Yasar N, Kumbasar AB. Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the colon. BMC Gastroenterol 2008, 8:35. 10.1186/1471-230X-8-35, 2527302, 18702825.
30. International Agency for Research on Cancer Monographs 1994, WHO.
31. Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther 2013, 38(4):329-342. 10.1111/apt.12380, 23786250.
32. Rokkas T, Sechopoulos P, Pistiolas D, Kothonas F, Margantinis G, Koukoulis G. The relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis. Eur J Gastroenterol Hepatol 2013, 25(11):1286-1294. 10.1097/MEG.0b013e328363d3cd, 23820245.
33. Malaty HM, Evans DG, Evans DJ, Graham DY. Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 1992, 103(3):813-816.
34. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut 2008, 57(11):1545-1553. 10.1136/gut.2008.159723, 18676420.
35. Smoot DT, Collins J, Dunlap S, Ali-Ibrahim A, Nouraie M, Lee EL, Ashktorab H. Outcome of colonoscopy in elderly African-American patients. Dig Dis Sci 2009, 54(11):2484-2487. 10.1007/s10620-009-0965-3, 19757049.
36. Griffith KA, McGuire DB, Royak-Schaler R, Plowden KO, Steinberger EK. Influence of family history and preventive health behaviors on colorectal cancer screening in African Americans. Cancer 2008, 113(2):276-285. 10.1002/cncr.23550, 18543276.
37. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988, 83(5):504-509.
38. Perez-Perez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, Zhang L, You WC, Blaser MJ. Country-specific constancy by age in cagA + proportion of Helicobacter pylori infections. Int J Cancer 1997, 72(3):453-456. 10.1002/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CO;2-D, 9247289.
39. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988, 109(1):11-17. 10.7326/0003-4819-109-1-11, 3288028.
40. Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992, 102(1):41-46.
41. Perez-Perez GI, Brown WR, Cover TL, Dunn BE, Cao P, Blaser MJ. Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. Clin Diagn Lab Immunol 1994, 1(3):325-329. 368256, 7496970.
42. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol 1991, 29(8):1635-1639. 270176, 1761685.
43. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995, 55(10):2111-2115.
44. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995, 87(23):1777-1780. 10.1093/jnci/87.23.1777, 7473834.
45. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006, 11(2):75-80. 10.1111/j.1523-5378.2006.00381.x, 16579836.
46. Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship?. World J Surg Oncol 2007, 5:51. 10.1186/1477-7819-5-51, 1885433, 17498313.
47. Kibreab A, Dowlati E, Nouraie M, Brim H, Lee E, Scott V, Smoot DT, Ashktorab H. Colorectal neoplasia in young African Americans, could race be a risk factor? A 40 years experience in an inner city teaching hospital. Gastereoentrology 2009, 136:A337.
48. Nouraie M, Hosseinkhah F, Brim H, Zamanifekri B, Smoot DT, Ashktorab H. Clinicopathological features of colon polyps from African-Americans. Dig Dis Sci 2010, 55(5):1442-1449. 10.1007/s10620-010-1133-5, 3702046, 20225129.
49. Giesecke J. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993, 341(8857):1359-1362. 10.1016/0140-6736(93)90938-D, 8098787.
50. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 1999, 60(3):210-215. 10.1159/000007661, 10343134.
51. Misra V, Misra SP, Singh MK, Singh PA, Dwivedi M. Prevalence of H. pylori in patients with gastric cancer. Indian J Pathol Microbiol 2007, 50(4):702-707.
52. Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010, 21(1):163-170. 10.1007/s10552-009-9446-4, 3510266, 19838812.
53. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995, 345(8964):1525-1528. 10.1016/S0140-6736(95)91084-0, 7791437.
54. Villako K, Kekki M, Maaroos HI, Sipponen P, Uibo R, Tammur R, Tamm A. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl 1991, 186:135-141.
55. Jung A, Vieth M, Maier O, Stolte M. Fundic gland polyps (Elster's cysts) of the gastric mucosa. A marker for colorectal epithelial neoplasia?. Pathol Res Pract 2002, 198(11):731-734. 10.1078/0344-0338-00328, 12530575.
56. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Hanaoka T, Tsugane S. Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter 2007, 12(4):328-332. 10.1111/j.1523-5378.2007.00513.x, 17669106.
57. Yang MH, Son HJ, Lee JH, Kim MH, Kim JY, Kim YH, Chang DK, Rhee PL, Kim JJ, Rhee JC. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas. Gastrointest Endosc 2010, 71(4):774-781. 10.1016/j.gie.2009.11.042, 20363417.
58. Doetschman T. GI GEMs: genetically engineered mouse models of gastrointestinal disease. Gastroenterology 2011, 140(2):380-385. e382, 10.1053/j.gastro.2010.12.013, 3116267, 21167162.